TY - JOUR
T1 - Differential regulation of cardiac sodium channels by intracellular fibroblast growth factors
AU - Angsutararux, Paweorn
AU - Dutta, Amal K.
AU - Marras, Martina
AU - Abella, Carlota
AU - Mellor, Rebecca L.
AU - Shi, Jingyi
AU - Nerbonne, Jeanne M.
AU - Silva, Jonathan R.
N1 - Funding Information:
The authors thank Dr. A. Burkhalter for assistance with and training in retro-orbital virus injections, Drs. M. Goldfarb and D. Ornitz for providing the Fgf12KO mouse line, Dr. G. Pitt for the polyclonal anti-iFGF13 antibody, and R. Wilson for expert technical assistance. We gratefully acknowledge the financial support provided by the National Heart Lung and Blood Institute of the NIH (R01 142520 to J.M. Nerbonne and R01 HL150637 to J.M. Nerbonne and J.R. Silva), the NIH National Center for Research Resources (UL1 RR024992 to the Institute for Clinical and Translational Sciences at Washington University), and the Children’s Discovery Institute Pediatric Disease Mouse Models Core at Washington University. Viruses were generated in the Hope Center Viral Vectors Core, supported by a Neuroscience Blueprint Core grant (P30 NS057105) at Washington University Medical School. None of these funding sources were involved in study design, data collection, data analyses, data interpretation, manuscript preparation, or the decision to submit this article for consideration for publication. The authors declare no competing financial interests.
Publisher Copyright:
© 2023 Angsutararux et al.
PY - 2023/5/1
Y1 - 2023/5/1
N2 - Voltage-gated sodium (NaV) channels are responsible for the initiation and propagation of action potentials. In the heart, the predominant NaV1.5 α subunit is composed of four homologous repeats (I–IV) and forms a macromolecular complex with multiple accessory proteins, including intracellular fibroblast growth factors (iFGF). In spite of high homology, each of the iFGFs, iFGF11–iFGF14, as well as the individual iFGF splice variants, differentially regulates NaV channel gating, and the mechanisms underlying these differential effects remain elusive. Much of the work exploring iFGF regulation of NaV1.5 has been performed in mouse and rat ventricular myocytes in which iFGF13VY is the predominant iFGF expressed, whereas investigation into NaV1.5 regulation by the human heart-dominant iFGF12B is lacking. In this study, we used a mouse model with cardiac-specific Fgf13 deletion to study the consequences of iFGF13VY and iFGF12B expression. We observed distinct effects on the voltage-dependences of activation and inactivation of the sodium currents (INa), as well as on the kinetics of peak INa decay. Results in native myocytes were recapitulated with human NaV1.5 heterologously expressed in Xenopus oocytes, and additional experiments using voltage-clamp fluorometry (VCF) revealed iFGF-specific effects on the activation of the NaV1.5 voltage sensor domain in repeat IV (VSD-IV). iFGF chimeras further unveiled roles for all three iFGF domains (i.e., the N-terminus, core, and C-terminus) on the regulation of VSD-IV, and a slower time domain of inactivation. We present here a novel mechanism of iFGF regulation that is specific to individual iFGF isoforms and that leads to distinct functional effects on NaV channel/current kinetics.
AB - Voltage-gated sodium (NaV) channels are responsible for the initiation and propagation of action potentials. In the heart, the predominant NaV1.5 α subunit is composed of four homologous repeats (I–IV) and forms a macromolecular complex with multiple accessory proteins, including intracellular fibroblast growth factors (iFGF). In spite of high homology, each of the iFGFs, iFGF11–iFGF14, as well as the individual iFGF splice variants, differentially regulates NaV channel gating, and the mechanisms underlying these differential effects remain elusive. Much of the work exploring iFGF regulation of NaV1.5 has been performed in mouse and rat ventricular myocytes in which iFGF13VY is the predominant iFGF expressed, whereas investigation into NaV1.5 regulation by the human heart-dominant iFGF12B is lacking. In this study, we used a mouse model with cardiac-specific Fgf13 deletion to study the consequences of iFGF13VY and iFGF12B expression. We observed distinct effects on the voltage-dependences of activation and inactivation of the sodium currents (INa), as well as on the kinetics of peak INa decay. Results in native myocytes were recapitulated with human NaV1.5 heterologously expressed in Xenopus oocytes, and additional experiments using voltage-clamp fluorometry (VCF) revealed iFGF-specific effects on the activation of the NaV1.5 voltage sensor domain in repeat IV (VSD-IV). iFGF chimeras further unveiled roles for all three iFGF domains (i.e., the N-terminus, core, and C-terminus) on the regulation of VSD-IV, and a slower time domain of inactivation. We present here a novel mechanism of iFGF regulation that is specific to individual iFGF isoforms and that leads to distinct functional effects on NaV channel/current kinetics.
UR - http://www.scopus.com/inward/record.url?scp=85150672810&partnerID=8YFLogxK
U2 - 10.1085/jgp.202213300
DO - 10.1085/jgp.202213300
M3 - Article
C2 - 36944081
AN - SCOPUS:85150672810
SN - 0022-1295
VL - 155
JO - Journal of General Physiology
JF - Journal of General Physiology
IS - 5
M1 - e202213300
ER -